San Diego-based medical device company SpectraScience has begun initial shipments of its WavSTAT4 Optical Biopsy System to Pentax Europe under the exclusive, five-year distribution agreement announced earlier this month.
The agreement includes the shipment of WavSTAT4 mobile console and disposable optical biopsy forceps initially to Europe and later to Turkey, Saudi Arabia, and South Africa as well.
SpectraScience chief executive officer Michael Oliver said this initial order for delivery of systems intended for customers in The Netherlands, France, Germany and the UK reflects Pentax' strategy to quickly incorporate WavSTAT4 into their colorectal screening business.
"Our engineering and manufacturing teams are in the process of ramping up training programs and production plans to make certain we provide everything PENTAX requires under the agreement," Oliver said.
Designed to be used as an adjunct to existing endoscopic procedures, the WavSTAT4 Optical Biopsy System can provide an in vivo diagnosis of possible cancerous tissue immediately during a typical colorectal screening.
The system console immediately displays results of the WavSTAT4 diagnosis, which may include a red icon denoting cancerous tissue and a green icon for normal tissue.
